{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:19:09Z","timestamp":1790687949005,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T00:00:00Z","timestamp":1109635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2005,3]]},"DOI":"10.1016\/j.eururo.2004.10.009","type":"journal-article","created":{"date-parts":[[2004,11,8]],"date-time":"2004-11-08T18:47:18Z","timestamp":1099939638000},"page":"302-307","source":"Crossref","is-referenced-by-count":12,"title":["Complexed Prostate Specific Antigen Density is Better Than the Other PSA Derivatives for Detection of Prostate Cancer in Men with Total PSA between 2.5 and 20ng\/ml: Results of a Prospective Multicenter Study"],"prefix":"10.1016","volume":"47","author":[{"given":"Sinan","family":"S\u00f6zen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saadettin","family":"Eskicorapci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bora","family":"K\u00fcpeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lokman","family":"\u0130rkilata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mert","family":"Altinel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00f6khan","family":"\u00d6zer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cemil","family":"Uygur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Turgut","family":"Alkibay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haluk","family":"\u00d6zen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2004.10.009_bib1","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0022-5347(05)68543-6","article-title":"Prostate specific antigen: A decade of discovery- what we have learned and where we are going","volume":"162","author":"Polascik","year":"1999","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2004.10.009_bib2","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3322\/canjclin.49.1.8","article-title":"Cancer statistics","volume":"49","author":"Landis","year":"1999","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.eururo.2004.10.009_bib3","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0090-4295(00)00637-3","article-title":"Comparison of percent free PSA, PSA density, and age-specific PSA cut-offs for prostate cancer detection and staging","volume":"56","author":"Catalona","year":"2000","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2004.10.009_bib4","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0022-5347(05)67986-4","article-title":"Examination of the 3 molecular forms of serum prostate specific antigen for distinguishing negative from positive biopsy: Relationship to transition zone volume","volume":"163","author":"Stamey","year":"2000","journal-title":"J Urol"},{"issue":"4A","key":"10.1016\/j.eururo.2004.10.009_bib5","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/S0090-4295(02)01896-4","article-title":"Complexed prostate-specific antigen, complexed prostate-specific antigen density of total and transition zone, complexed\/total prostate-specific antigen ratio, free-to-total prostate-specific antigen ratio, density of total and transition zone prostate-specific antigen: Results of the prospective multicenter European trial","volume":"60","author":"Djavan","year":"2002","journal-title":"Urology"},{"issue":"2","key":"10.1016\/j.eururo.2004.10.009_bib6","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1200\/JCO.2003.02.083","article-title":"Biology of prostate specific antigen","volume":"21","author":"Balk","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2004.10.009_bib7","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0090-4295(99)00149-1","article-title":"Complexed prostate-specific antigen and its volume indexes in the detection of prostate cancer","volume":"54","author":"Maeda","year":"1999","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2004.10.009_bib8","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1002\/cncr.10377","article-title":"Prostate specific antigen complexed to \u03b1-1-antichymotrypsin in patients with intermediate prostate specific antigen levels","volume":"94","author":"Saika","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.eururo.2004.10.009_bib9","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0959-8049(00)00355-5","article-title":"Incidence in \u0130zmir in 1993-1994: first results from \u0130zmir Cancer Registry","volume":"37","author":"Fidaner","year":"2001","journal-title":"European Journal of Cancer"},{"issue":"6","key":"10.1016\/j.eururo.2004.10.009_bib10","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1097\/00000421-200112000-00017","article-title":"Combined use of prostate-specific antigen derivatives decreases the number of unnecessary biopsies to detect prostate cancer","volume":"24","author":"Ozen","year":"2001","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.eururo.2004.10.009_bib11","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/S0022-5347(05)64543-0","article-title":"Robustness of free prostate specific antigen measurements to reduce unnecessary biopsies in the 2.6 to 4.0ng\/ml range","volume":"168","author":"Roehl","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2004.10.009_bib12","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1093\/clinchem\/37.9.1618","article-title":"Prostate-specific antigen in serum occurs predominantly in complex with alpha 1- antichymotrypsin","volume":"37","author":"Lilja","year":"1991","journal-title":"Clin Chem"},{"key":"10.1016\/j.eururo.2004.10.009_bib13","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/S0090-4295(98)00617-7","article-title":"Free\/total PSA ratio improves differentiation of benign and malignant disease of the prostate: critical analysis of two different test populations","volume":"53","author":"Veltri","year":"1999","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2004.10.009_bib14","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S0090-4295(98)00241-6","article-title":"Measurement of complexed PSA improves specificity for early detection of prostate cancer","volume":"52","author":"Brawer","year":"1998","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2004.10.009_bib15","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1097\/01.ju.0000087560.30497.4e","article-title":"A multicenter clinical trial on the use of complexed prostate specific antigen in low prostate specific antigen concentrations","volume":"170","author":"Lein","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2004.10.009_bib16","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1097\/01.ju.0000092695.55705.dd","article-title":"Complexed prostate specific antigen improves specificity for prostate cancer detection: results of a prospective multicenter clinical trial","volume":"170","author":"Partin","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2004.10.009_bib17","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/clinchem\/46.1.55","article-title":"Ratio of free or complexed prostate specific antigen (PSA) to total PSA: Which ratio improves differentiation between benign prostatic hyperplasia and prostate cancer?","volume":"46","author":"Jung","year":"2000","journal-title":"Clin Chem"},{"key":"10.1016\/j.eururo.2004.10.009_bib18","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1016\/S0022-5347(01)64704-9","article-title":"Prostate specific antigen in benign prostatic hyperplasia: purification and characterization","volume":"157","author":"Chen","year":"1997","journal-title":"J Urol"},{"issue":"Suppl. 4A","key":"10.1016\/j.eururo.2004.10.009_bib19","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0090-4295(02)01696-5","article-title":"Can volume measurement of the prostate enhance the performance of complexed prostate-specific antigen?","volume":"60","author":"Naya","year":"2002","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2004.10.009_bib20","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0090-4295(02)01693-X","article-title":"Complexed prostate-specific antigen for early detection of prostate cancer in men with serum prostate-specific antigen levels of 2 to 4 nanograms per milliliter","volume":"60","author":"Horninger","year":"2002","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2004.10.009_bib21","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1464-410X.2004.04899.x","article-title":"Complexed prostate specific antigen (PSA) reduces unnecessary prostate biopsies in the 2.6-4.0ng\/ml range of total PSA","volume":"94","author":"Parsons","year":"2004","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2004.10.009_bib22","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/(SICI)1097-0045(1996)7+<3::AID-PROS1>3.0.CO;2-T","article-title":"Discordance of assay methods creates pitfalls for the interpretation of prostate specific antigen values","volume":"7","author":"Semjonow","year":"1996","journal-title":"Prostate Suppl"},{"key":"10.1016\/j.eururo.2004.10.009_bib23","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1016\/S0022-5347(17)39789-6","article-title":"Comparison of a polyclonal and monoclonal immunoassay for PSA: need for an international antigen standard","volume":"144","author":"Graves","year":"1990","journal-title":"J Urology"},{"key":"10.1016\/j.eururo.2004.10.009_bib24","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0090-4295(96)00606-1","article-title":"Comparison of three assays for total serum prostate-specific antigen and percentage of free prostate specific antigen in predicting prostate histology","volume":"48","author":"Roehrborn","year":"1996","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2004.10.009_bib25","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1093\/clinchem\/38.10.2140","article-title":"Abbott IMx evaluated for assay of prostate-specific antigen in serum","volume":"38","author":"Dnistrian","year":"1992","journal-title":"Clin Chem"},{"key":"10.1016\/j.eururo.2004.10.009_bib26","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1097\/01.ju.0000127736.86597.e7","article-title":"Variation in prostate specific antigen results from 2 different assay platforms: Clinical impact on 2,304 patients undergoing prostate cancer screening","volume":"171","author":"L\u0131nk","year":"2004","journal-title":"J Urol"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283804005160?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283804005160?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T22:33:45Z","timestamp":1585953225000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283804005160"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,3]]}},"alternative-id":["S0302283804005160"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2004.10.009","relation":{},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2005,3]]}}}